A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

11.2K views

DOI:

10.3791/56443

April 13th, 2018

In This Article

Summary

We describe a non-invasive multimodal imaging approach based on Micro-CT and fluorescence molecular tomography for longitudinal assessment of the mouse lung fibrosis model induced by double intratracheal instillation of bleomycin.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by the progressive and irreversible destruction of lung architecture, which causes significant deterioration in lung function and subsequent death from respiratory failure.

The pathogenesis of IPF in experimental animal models has been induced by bleomycin administration. In this study, we investigate an IPF-like mouse model induced by a double intratracheal bleomycin instillation. Standard histological assessments used for studying lung fibrosis are invasive terminal procedures. The goal of this work is to monitor lung fibrosis through noninvasive imaging techniques such as Fluorescent Molecular Tomography (FMT) and Micro-CT. These two technologies validated with histology findings could represent a revolutionary functional approach for real time non-invasive monitoring of IPF disease severity and progression. The fusion of different approaches represents a step further for understanding the IPF disease, where the molecular events occurring in a pathological condition can be observed with FMT and the subsequent anatomical changes can be monitored by Micro-CT.

Introduction

Idiopathic pulmonary fibrosis (IPF) is chronic lung disease with progressive decrease of lung functions that is unfortunately often fatal within four years of diagnosis1. The major features of IPF are extracellular matrix deposition and fibroblast proliferation, but the pathogenesis is not yet fully understood. The most supported hypothesis is that multiple cycles of lung injuries cause the destruction of alveolar epithelial cells that leads to alteration of the mesenchymal cell cycle proliferation, exaggerated accumulation of fibroblasts and myofibroblasts, and increased matrix production. Mediators involved in these processes such as matrix m....

Access restricted. Please log in or start a trial to view this content.

Protocol

All animal experiments described herein were approved by the intramural animal-welfare committee for animal experimentation of Chiesi Farmaceutici and ERASMUS MC under protocol number: EMC 3349 (138-14-07) complying with the European Directive 2010/63 UE, Italian D.Lgs 26/2014 and the revised "Guide for the Care and Use of Laboratory Animals"23.

NOTE: Prior to use, female inbred C57Bl/6 (7-8 weeks old) mice were acclimatized for at least 7 days to the local vivarium conditions (room temperature: 20-24 °C; relative humidity: 40-70%; 12-h light-dark cycle), having free access to standard rodent chow and so....

Access restricted. Please log in or start a trial to view this content.

Results

Spontaneous resolution of the lung fibrosis lesions observed three weeks after single bleomycin administration and moderate structural changes highlight the limits of this model. Only preventive treatment could be performed due to the narrow therapeutic window that does not represent clinical practice17.

Here, we demonstrate that our protocol of double bleomycin intratracheal instillation is able to devel.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Despite many research groups focusing on developing new drugs to treat IPF, at the moment only two are available for patients. There is an urgent medical need to find more effective therapies7 because only lung transplantationis able to prolong survival of 4-5 years26. The essential prerequisite for translational medicine and development of new drugs is the availability of an animal model that mimics the features of IPF and in which interventional studies are predictive of .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing interests.

Acknowledgements

The authors would like to thank Dr. Daniela Pompilio and Roberta Ciccimarra for technical help.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
FMT 2500 Fluorescence Tomography SystemPerkin Elmer Inc.Experimental Builder
MMPsense 680Perkin Elmer Inc.NEV10126Protect from light, store the probe at 4 °C
TrueQuant softwarePerkin Elmer Inc.
Female inbred C57BL/6San Pietro NatisoneHorst, The Netherlands (UD), Prior to use, animals were acclimatized for at least 5 days to the local vivarium conditions
IsofluraneESTEVE spa571329.8Do not inhale
Automated cell counterDasit XT 1800JExperimental Builder
Saline Solution, 0.9% Sodium Chloride (NaCl)Eurospital15A2807
Quantum FX Micro-CT scanner Perkin Elmer Inc.
Bleomycin sulphate from Streptomyces Verticillus Sigma B2434 
Automatic tissue Processor ATP700 Histo-Line LaboratoriesATP700 
Embedding system EG 1160 Leica BiosystemsEG 1160
Rotary microtome Slee Cut 6062
Digital slide scanner NanoZoomer S60, Hamamatsu Photonics
NIS-AR image analysis software Nikon
Masson’s Trichrome StainingHisto-Line Laboratories
10% neutral-buffered formalinSigmaHT5012-1CS
Penn-century model DP-4M Dry power insufflatorPenn-centuryDPM-EXT
PE190 micro medical tubing2biological instruments sncBB31695-PE/8
Syringe without needle 5 mLTerumoSS*05SE1Cut the boards of the piston by scissors
Hamilton 0.10 mL (model 1710)Gastight81022
Discofix 3-way StopcockBraun4095111
Syringe with needle 1 mLPic solution3,071,260,300,320Use without needle
Plastic feeding tubes 18 ga x 50 mm2biological instruments sncFTP-18-50Cut obliquely the tip 

References

  1. Wynn, T. A. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208 (7), 1339-1350 (2011).
  2. Wynn, T. A., Ramalingam, T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18 (7), 1028-1040 (2012).
  3. Moore, B. B.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Micro CT ImagingNoninvasive ImagingLung Fibrosis MonitoringMouse ModelFMT Micro CT FusionAirway QuantificationHistological Validation